(S (S (NP-SBJ-11 (JJ Human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I) (NN Tax)) (VP (VP-COOD (VP (VBZ associates) (PP (IN with) (NP (-NONE- *RNR*-12)))) (CC and) (VP (VBZ is) (VP (ADVP (RB negatively)) (VBN regulated) (NP (-NONE- *-11)) (PP (IN by) (NP-LGS (-NONE- *RNR*-12)))))) (NP-12 (DT the) (NN NF-kappa) (NN B2) (NN p100) (NN gene) (NN product))) (: :)) (NP (NP (NNS implications)) (PP (IN for) (NP (JJ viral) (NN latency))) (. .)))
(S (NP-SBJ (NP (JJ Human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ etiologic) (NN agent)) (PP (IN of) (NP (NP (DT the) (JJ adult) (NN T-cell) (NN leukemia)) (, ,) (NP (NP (DT an) (ADJP-COOD (ADJP (JJ aggressive)) (CC and) (ADJP (ADVP-TMP (RB often)) (JJ fatal))) (NN malignancy)) (PP (IN of) (NP (VBN activated) (JJ human) (NN CD4) (NN T) (NNS cells)))))))) (. .))
(S (NP-SBJ (NN HTLV-I)) (VP (VBZ encodes) (NP (NP (DT an) (JJ essential) (JJ 40-kDa) (NN protein)) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN Tax)))) (SBAR (WHNP-16 (WDT that)) (S (NP-SBJ (-NONE- *T*-16)) (VP-COOD (CONJP (RB not) (RB only)) (VP (VBZ transactivates) (NP (NP (DT the) (JJ long) (JJ terminal) (NN repeat)) (PP (IN of) (NP (DT this) (NN retrovirus))))) (CONJP (CC but) (RB also)) (VP (VBZ induces) (NP (NP (DT an) (NN array)) (PP (IN of) (NP (JJ cellular) (NNS genes)))))))))) (. .))
(S (NP-SBJ (NP (JJ Tax-mediated) (NN transformation)) (PP (IN of) (NP (NN T) (NNS cells)))) (ADVP (RB likely)) (VP (VBZ involves) (NP (NP (DT the) (VBN deregulated) (NN expression)) (PP (IN of) (NP (NP (JJ various) (JJ cellular) (NNS genes)) (SBAR (WHNP-15 (WDT that)) (S (NP-SBJ (-NONE- *T*-15)) (ADVP (RB normally)) (VP (VBP regulate) (NP (NP (NN lymphocyte) (NN growth)) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ altered) (NN activity)) (PP (IN of) (NP (JJ various) (JJ endogenous) (NN host) (NN transcription) (NNS factors)))))))))))))) (. .))
(S (PP (IN In) (NP (JJ particular))) (, ,) (NP-SBJ-13 (NN Tax)) (VP (VBZ is) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-13)) (VP (VBG modulating) (NP (NP (DT the) (NP-COOD (NP (NN expression)) (CC or) (NP (NN activity)))) (PP (IN of) (NP (NP (JJ various) (NN host) (NN transcription) (NNS factors)) (, ,) (PP (VBG including) (NP (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN NF-kappa) (NN (Rel B))) (CC and) (NP (NN (ATF CREB)))) (NNS families)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (JJ cellular) (NNS factors) (NP-COOD (NP (NN HEB-1)) (CC and) (NP (NN p67SRF)))))))))))))) (. .))
(S (NP-SBJ (NP (DT An) (JJ additional) (JJ distinguishing) (NN characteristic)) (PP (IN of) (NP (NN HTLV-I) (NN infection)))) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ profound) (NN state)) (PP (IN of) (NP (NP (JJ viral) (NN latency)) (SBAR (WHNP-14 (WDT that)) (S (NP-SBJ (-NONE- *T*-14)) (VP (VBZ is) (ADJP-PRD (JJ present) (PP (IN in) (NP (VBG circulating) (JJ primary) (JJ leukemic) (NN T) (NNS cells))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NN HTLV-I) (NN Tax)) (VP (MD can) (VP (ADVP (RB physically)) (VB associate) (PP (IN with) (NP (NP (NN p100)) (, ,) (NP (NP (DT the) (NN product)) (PP (IN of) (NP (DT the) (JJ Rel-related) (NN NF-kappa) (NN B2) (NN gene)))) (, ,))) (PP-COOD (CC both) (PP (IN in) (NP (VBN transfected) (NNS cells))) (CC and) (PP (IN in) (NP (JJ HTLV-I-infected) (JJ leukemic) (NN T-cell) (NNS lines))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (DT the) (JJ physical) (NN interaction)) (PP (IN of) (NP (NN Tax))) (PP (IN with) (NP (NN p100)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (JJ Tax-induced) (NN activation)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN HTLV-I)) (CC and) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))) (JJ long) (JJ terminal) (NNS repeats))))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG reflecting) (NP (NP (JJ p100-mediated) (JJ cytoplasmic) (NN sequestration)) (PP (IN of) (NP (DT the) (ADJP (ADVP (RB normally)) (RB nuclearly) (VBN expressed)) (NN Tax) (NN protein))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT a) (NN mutant)) (PP (IN of) (NP (NN Tax))) (SBAR (WHNP-18 (WDT that)) (S (NP-SBJ-19 (-NONE- *T*-18)) (ADVP (RB selectively)) (VP (VBZ fails) (S (NP-SBJ (-NONE- *-19)) (VP (TO to) (VP (VB activate) (NP (JJ nuclear) (NN NF-kappa) (NN B) (NN expression))))))))) (VP (VBZ does) (RB not) (VP (VB associate) (PP (IN with) (NP (NN p100))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-20 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-20)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
